Home > Result Summaries: Compounds > cefuroxime axetil Result Summaries: cefuroxime axetil GSKStudy ID Phase Title Summary (Download) CAE10004 Phase 1 A study to determine the bioequivalence of reformulated 125mg/5mL cefuroxime axetil oral suspension (CAOS) to standard marketed 125mg/5mL suspension at a dose of 250mg. (0 citation(s)) CAE10005 Phase 1 A study to determine the bioequivalence of reformulated 250mg/5mL cefuroxime axetil oral suspension (CAOS) to standard marketed 250mg/5mL suspension. (0 citation(s)) CAE40408 Phase 4 An open-label study of sequential therapy with intravenous cefuroxime followed by oral cefuroxime axetil for the treatment of community acquired pneumonia (CAP) (0 citation(s))
